Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC (Rac)-minzasolmin | 1802518-63-3 | 99.9% | 425.59 g/mol | C23H31N5OS | 10MG
Supplier: Medchemexpress LLC HY12528710MG
(Rac)-Minzasolmin is a racemic, brain-penetrant inhibitor of α-synuclein misfolding developed for research into synucleinopathies. It modulates early-stage aggregation, can revert membrane-bound oligomers to monomers, and has shown efficacy in α-synuclein transgenic models relevant to Parkinson's disease and dementia with Lewy bodies.
- Brain-penetrant small molecule suitable for in vivo and in vitro studies.
- Inhibits α-synuclein misfolding and early-stage aggregation.
- Promotes reversion of membrane-bound oligomers to monomers.
- Demonstrated activity in α-synuclein transgenic models.
- High purity for research use (≈99.9%).
- Molecular formula C23H31N5OS; molecular weight 425.59 g/mol.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?